Cargando…

Nonviral genome engineering of natural killer cells

Natural killer (NK) cells are cytotoxic lymphocytes of the innate immune system capable of immune surveillance. Given their ability to rapidly and effectively recognize and kill aberrant cells, especially transformed cells, NK cells represent a unique cell type to genetically engineer to improve its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robbins, Gabrielle M., Wang, Minjing, Pomeroy, Emily J., Moriarity, Branden S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207670/ https://www.ncbi.nlm.nih.gov/pubmed/34134774 http://dx.doi.org/10.1186/s13287-021-02406-6

Ejemplares similares

Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies
por: Matosevic, Sandro
Publicado: (2018)

The Molecular Imaging of Natural Killer Cells
por: Shapovalova, Mariya, et al.
Publicado: (2018)

Nonviral Methods for Inducing Pluripotency to Cells
por: O'Doherty, Ryan, et al.
Publicado: (2013)

Mesenchymal Stem Cells Engineered by Nonviral Vectors: A Powerful Tool in Cancer Gene Therapy
por: Ding, Yuan, et al.
Publicado: (2021)

Engineered Nonviral Protein Cages Modified for MR Imaging
por: Kaster, Megan A., et al.
Publicado: (2023)

Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
por: Shankar, Keerthana, et al.
Publicado: (2020)

CAR T-Cell Production Using Nonviral Approaches
por: Lukjanov, Viktor, et al.
Publicado: (2021)

Nonviral Interferon Inducers
por: Merigan, Thomas C., et al.
Publicado: (1970)

Nonviral Approaches for Neuronal Delivery of Nucleic Acids
por: Bergen, Jamie M., et al.
Publicado: (2007)

Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
por: Lamers-Kok, Nina, et al.
Publicado: (2022)

The prospect of genetically engineering natural killer cells for cancer immunotherapy
por: Poon, Angie Yu Ching, et al.
Publicado: (2022)

Nonviral Gene Therapy for Cancer: A Review
por: Hidai, Chiaki, et al.
Publicado: (2018)

Targeted nonviral gene therapy in prostate cancer
por: Altwaijry, Najla, et al.
Publicado: (2018)

Nonviral delivery systems for antisense oligonucleotide therapeutics
por: Huang, Si, et al.
Publicado: (2022)

Chimeric antigen receptor engineered natural killer cells for cancer therapy
por: Zhang, Yalan, et al.
Publicado: (2023)

Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy
por: Shu, Runzhe, et al.
Publicado: (2023)

Viral, nonviral and peptide-mediated intra-articular transfer of genes and proteins
por: Robbins, PD, et al.
Publicado: (2001)

Viral and nonviral delivery systems for gene delivery
por: Nayerossadat, Nouri, et al.
Publicado: (2012)

Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease
por: Johnson, Matthew J., et al.
Publicado: (2018)

Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
por: Yilmaz, Ahmet, et al.
Publicado: (2020)

Nonviral gene delivery system
por: Yang, Ningning
Publicado: (2012)

Research progress on siRNA delivery with nonviral carriers
por: Gao, Yan, et al.
Publicado: (2011)

Application of Peptides in Construction of Nonviral Vectors for Gene Delivery
por: Yang, Yujie, et al.
Publicado: (2022)

Induction and suppression of gene silencing in plants by nonviral microbes
por: Parperides, Eric, et al.
Publicado: (2023)

Roles of Natural Killer T Cells and Natural Killer Cells in Kidney Injury
por: Uchida, Takahiro, et al.
Publicado: (2019)

Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma
por: Kgatle, Mankgopo M., et al.
Publicado: (2016)

Suprachoroidal gene transfer with nonviral nanoparticles
por: Shen, Jikui, et al.
Publicado: (2020)

Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
por: Gong, Ying, et al.
Publicado: (2021)

Antitumor Immunity Exerted by Natural Killer and Natural Killer T Cells in the Liver
por: Nakashima, Hiroyuki, et al.
Publicado: (2023)

Infections, Reactions of Natural Killer T Cells and Natural Killer Cells, and Kidney Injury
por: Uchida, Takahiro, et al.
Publicado: (2022)

Engineering of chimeric natural killer cell receptors to develop precision adoptive immunotherapies for cancer
por: Obajdin, J., et al.
Publicado: (2020)

Correction of Fanconi Anemia Mutations Using Digital Genome Engineering
por: Sipe, Christopher J., et al.
Publicado: (2022)

Natural killer cells and autoimmunity
por: French, Anthony R, et al.
Publicado: (2004)

Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy
por: Wang, Yusi, et al.
Publicado: (2022)

Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
por: Iyoda, Tomonori, et al.
Publicado: (2023)

Comparative Genomics of Natural Killer Cell Receptor Gene Clusters
por: Kelley, James, et al.
Publicado: (2005)

Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors
por: Webber, Beau R., et al.
Publicado: (2019)

The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy
por: Fabian, Kellsye P., et al.
Publicado: (2021)

Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases
por: Kansara, Viral, et al.
Publicado: (2020)

The role of natural killer cell in gastrointestinal cancer: killer or helper
por: Wang, Feixue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fpv8e3cd99pu40spmq4159f2dn